Company intelligence / Profile preview

Tuo Jiding

Jiaxing, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Tuojiding (Jiaxing) Pharmaceutical Technology Co., Ltd. (Tuojiding) is an innovative biotechnology company and contract research organization (CRO) specializing in conjugate drug platform technologies. Founded in 2024 and headquartered in Jiaxing, China, the company provides advanced platform services to address critical bottlenecks in drug screening, biodistribution, pharmacokinetics, and pharmacodynamics. Tuojiding's proprietary platform is designed to empower conjugate drugs, enhance their therapeutic index, and accelerate pipeline translation for biopharmaceutical partners. In addition to its platform services, the company is developing radiopharmaceutical assets, including a small molecule PET imaging agent targeting the CXCR4 chemokine receptor.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Tuo Jiding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tuo Jiding.